Sanofi Seeks Double Vaccine Approval Nod In EU

The sponsors of up to seven new drugs or vaccines will find out this week whether their products will soon be approved in the EU. The products include two vaccines from Sanofi and what is possibly the first generic rival to Bayer's Xarelto to be assessed by the European Medicines Agency.

Meningococcal vaccination
Sanofi's meningococcal disease vaccine could be approved in Europe soon • Source: Shutterstock

The seven marketing authorization applications (MAAs) that are up for an opinion this week on whether they should be marketed in the EU include two vaccines from Sanofi – one for the prevention of invasive meningococcal disease, including meningitis, and one for flu.

Also up for an opinion is a generic version of rivaroxaban. This appears to be the first generic version of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet